
Sign up to save your podcasts
Or
In this episode of Perception Paradox, Zivile interviews Daniel Oliver, the founder of Capital Cell, a leading biotech crowdfunding platform in Europe.
Together, they delve into the evolving landscape of biotech investment, discussing the challenges of fundraising, and the importance of crowdfunding in the biotech sector. Daniel shares insights on the current landscape of biotech, the role of scientists in startups, and the cultural barriers to cross-border investments in Europe. He emphasizes the need for businesses to improve the world and reflects on his personal journey, offering valuable insights for aspiring entrepreneurs.
This episode explores the exciting world of biotech and provides valuable insights for anyone interested in innovation, investment, and the future of healthcare.
About Daniel:
Daniel is the founder and director of Capital Cell, Europe’s first equity crowdfunding platform specialising in the Healthcare sector.
With a scientific background (a degree in Biology from the Universitat de Barcelona), Daniel has been working in the financial sector since 2013 when he launched Creoentuproyecto.com, a now extinct investment crowdfunding platform best known for raising a record-breaking €3M for a digital newspaper (El Español).
In 2015 he founded Capital Cell, an investment platform focused exclusively in Healthcare. As of 2024, Capital Cell has invested 107 million euros in over 120 companies, making it one of the most active Biotech investors in Europe.
Since 2022 Daniel is also a partner at Nara Capital, an early-stage Venture Capital specialising in biotechnology, and also based in Barcelona.
🎙️ Hosted by Zivile Einikyte:
https://www.perceptionparadox.com
LinkedIn:
https://www.linkedin.com/in/zivileeinikyte/
🎵 Music by Luca Nioi:
http://www.lucanioi.com/
Chapters
00:00 Intro
01:12 The Birth of Capital Cell
10:30 The Evolution of Biotech Investment
17:27 Navigating the Funding Landscape
22:48 Cross-Border Investment Challenges
29:05 The Role of Crowdfunding in Biotech
35:50 Future Trends in Biotechnology
39:02 Resilience in Entrepreneurship
In this episode of Perception Paradox, Zivile interviews Daniel Oliver, the founder of Capital Cell, a leading biotech crowdfunding platform in Europe.
Together, they delve into the evolving landscape of biotech investment, discussing the challenges of fundraising, and the importance of crowdfunding in the biotech sector. Daniel shares insights on the current landscape of biotech, the role of scientists in startups, and the cultural barriers to cross-border investments in Europe. He emphasizes the need for businesses to improve the world and reflects on his personal journey, offering valuable insights for aspiring entrepreneurs.
This episode explores the exciting world of biotech and provides valuable insights for anyone interested in innovation, investment, and the future of healthcare.
About Daniel:
Daniel is the founder and director of Capital Cell, Europe’s first equity crowdfunding platform specialising in the Healthcare sector.
With a scientific background (a degree in Biology from the Universitat de Barcelona), Daniel has been working in the financial sector since 2013 when he launched Creoentuproyecto.com, a now extinct investment crowdfunding platform best known for raising a record-breaking €3M for a digital newspaper (El Español).
In 2015 he founded Capital Cell, an investment platform focused exclusively in Healthcare. As of 2024, Capital Cell has invested 107 million euros in over 120 companies, making it one of the most active Biotech investors in Europe.
Since 2022 Daniel is also a partner at Nara Capital, an early-stage Venture Capital specialising in biotechnology, and also based in Barcelona.
🎙️ Hosted by Zivile Einikyte:
https://www.perceptionparadox.com
LinkedIn:
https://www.linkedin.com/in/zivileeinikyte/
🎵 Music by Luca Nioi:
http://www.lucanioi.com/
Chapters
00:00 Intro
01:12 The Birth of Capital Cell
10:30 The Evolution of Biotech Investment
17:27 Navigating the Funding Landscape
22:48 Cross-Border Investment Challenges
29:05 The Role of Crowdfunding in Biotech
35:50 Future Trends in Biotechnology
39:02 Resilience in Entrepreneurship